Present updated data from RP2 clinical trial
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 11 Jan 2021
- Due
- 30 Jun 2021
- Delivered
- June 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Updated data from this clinical trial is expected to be presented mid-year.”
What we found
Evidence strength A What the grades mean
The company presented updated data from the RP2 clinical trial in June 2021, which falls within the mid-year 2021 deadline.
-
A Replimune Group, Inc. 10-Q filed 2021-08-06
“In June 2021 we presented a data update from both the RP2 single agent and combination portions of this clinical trial” ✓ confirmed on the page
Market reaction: the shares moved -11.5% against the S&P 500 over the three sessions around the disclosure (5 Aug 2021 to 10 Aug 2021). What this measures
Checked 24 Oct 2026.
Commitment lineage
Every time the company restated this commitment. The original is never changed, and the outcome is always measured against version 1.
- Deadline drift +274 days
- 2 versions
-
Version 1 · original · stated 11 Jan 2021
Deadline 30 Jun 2021 (“mid-year”) · wording expected
-
Version 2 · stated 4 Nov 2021
Deadline 31 Mar 2022 (“first quarter of 2022”) · wording firm
“The Company remains on track to present initial data from this clinical trial in the first quarter of 2022.”
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Present
- Deliverable
- updated clinical trial data
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Replimune Group, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-REPL-021464 · Corrections policy